Pharmacokinetics of Afatinib after Intravenous and Oral Administrations in Rats Using Validated UPLC MS/MS Assay.

已完结 20 由 YAN 发布于 2026/8/28 9:18:12

DOI:10.1093/chromsci/bmac110
作者：Alanood S Almurshedi,?Mahasen A Radwan,?Bushra Al Quadeib,?Basmah Aldosari,?Iman M Alfagih,?Salma S Almarshidy
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Afatinib is designated as the first-line management therapy for patients with advanced non-small cell lung cancer, and metastatic head and neck cancer. LC coupled to MS/MS can be utilised in

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库CO<sub>2</sub>-to-CO Electrolysis in Pure Water at Ampere-Level Current Density and 1000?h Stability via a Rapid-Transport Fixed-Charge Interface.